Get started
Author

Sarah Vasicek

Observed names: S Vasicek, S. Vasicek, Sarah M. Vasicek, Sarah Marvis Vasicek
OpenAlex ID: A5080245252
DRH1 – a novel blood-based HPV tumour marker
2020 · Thomas Weiland, Alexander Eckert, et al. · EBioMedicine · 28
PDF
C‐reactive protein is an independent prognostic marker in patients with tongue carcinoma ‐ A retrospective study
2018 · M. Graupp, K. Schaffer, et al. · Clinical Otolaryngology · 13
Preservation of nasal turbinates in endoscopic, anterior skull base surgery—yes, we can!
2021 · Axel Wolf, Alexandros Andrianakis, et al. · European Archives of Oto-Rhino-Laryngology · 8
PDF
Carotid endarterectomy significantly improves postoperative laryngeal sensitivity
2016 · Georg Philipp Hammer, Peter Valentin Tomazic, et al. · Journal of Vascular Surgery · 8
PDF
Decrease in treatment intensity predicts worse outcome in patients with locally advanced head and neck squamous cell carcinoma undergoing radiochemotherapy
2020 · S. Mollnar, P. Pondorfer, et al. · Clinical & Translational Oncology · 6
PDF
Head and neck cancer in Styria: An epidemiologic and clinical audit
2020 · Sarah M. Vasicek, Prisca Pondorfer, et al. · Wiener klinische Wochenschrift · 4
PDF
DRH1 - Evaluierung eines Blut-basierten Markers für HPV16-induzierte Tumore
2020 · T Weiland, PV Tomazic, et al. · Laryngo-Rhino-Otologie
DRH1 – Evaluating a blood-based marker for HPV16-induced tumors
2020 · T Weiland, Peter Valentin Tomazic, et al. · Laryngo-Rhino-Otologie
C-reactive protein as prognostic marker in patients with p16-negative vs. p16-positive oropharyngeal squamous cell carcinoma
2020 · P Pondorfer-Schäfer, Sarah Marvis Vasicek, et al. · Laryngo-Rhino-Otologie
Response to C‐reactive protein as an individual prognostic marker in oral cancer: practical considerations
2018 · M. Graupp, K. Schaffer, et al. · Clinical Otolaryngology
Works count: 10
Citation count: 67
H-index: 5
I10-index: 2
Year
Topic
Type